Anthera Pharmaceuticals Valuation
| ANTHDelisted Stock | USD 0.0001 0.00 0.00% |
Anthera Pharmaceuticals seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Anthera Pharmaceuticals from analyzing the firm fundamentals such as Return On Equity of -5.69, number of shares shorted of 2.02 M, and Current Valuation of (7.47 M) as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Anthera Pharmaceuticals' price fluctuation is very steady at this time. Calculation of the real value of Anthera Pharmaceuticals is based on 3 months time horizon. Increasing Anthera Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Anthera Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anthera Pink Sheet. However, Anthera Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.0E-4 | Real 8.5E-5 | Hype 1.0E-4 | Naive 1.0E-4 |
The intrinsic value of Anthera Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Anthera Pharmaceuticals' stock price.
Estimating the potential upside or downside of Anthera Pharmaceuticals helps investors to forecast how Anthera pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anthera Pharmaceuticals more accurately as focusing exclusively on Anthera Pharmaceuticals' fundamentals will not take into account other important factors: Anthera Pharmaceuticals Total Value Analysis
Anthera Pharmaceuticals is presently anticipated to have valuation of (7.47 M) with market capitalization of 617.83 K, debt of 0, and cash on hands of 8.09 M. The negative valuation of Anthera Pharmaceuticals may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Anthera Pharmaceuticals fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(7.47 M) | 617.83 K | 0 | 8.09 M |
Anthera Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Anthera is to check how much profit was generated for every dollar of assets it reports. Anthera Pharmaceuticals shows a negative utilization of assets of -1.42 percent, losing $0.0142 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Anthera Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Anthera Pharmaceuticals Profitability Analysis
Net Loss for the year was (26.87 M) with loss before overhead, payroll, taxes, and interest of (28.49 M).About Anthera Pharmaceuticals Valuation
An absolute valuation paradigm, as applied to Anthera Pink Sheet, attempts to find the value of Anthera Pharmaceuticals based on its fundamental and basic technical indicators. By analyzing Anthera Pharmaceuticals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Anthera Pharmaceuticals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anthera Pharmaceuticals. We calculate exposure to Anthera Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anthera Pharmaceuticals's related companies.Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. Anthera Pharmaceuticals, Inc. was founded in 2004 and is based in Houston, Texas. Anthera Pharmaceuticals operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 21 people.
8 Steps to conduct Anthera Pharmaceuticals' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Anthera Pharmaceuticals' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Anthera Pharmaceuticals' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Anthera Pharmaceuticals' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Anthera Pharmaceuticals' revenue streams: Identify Anthera Pharmaceuticals' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Anthera Pharmaceuticals' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Anthera Pharmaceuticals' growth potential: Evaluate Anthera Pharmaceuticals' management, business model, and growth potential.
- Determine Anthera Pharmaceuticals' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Anthera Pharmaceuticals' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Anthera Pharmaceuticals Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 10.3 M | |
| Retained Earnings | -434.4 M | |
| Shares Float | 26.1 M | |
| Retained Earnings Total Equity | -434.4 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Consideration for investing in Anthera Pink Sheet
If you are still planning to invest in Anthera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Anthera Pharmaceuticals' history and understand the potential risks before investing.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |